Kits Eyecare Ltd.
KTYCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $38 | $50 | $47 | $45 |
| % Growth | -24.1% | 6.4% | 3.9% | – |
| Cost of Goods Sold | $25 | $32 | $29 | $29 |
| Gross Profit | $13 | $18 | $17 | $16 |
| % Margin | 34.2% | 36.3% | 36.7% | 36.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $4 | $3 | $3 |
| SG&A Expenses | $10 | $11 | $9 | $9 |
| Sales & Mktg Exp. | $7 | $8 | $6 | $7 |
| Other Operating Expenses | $1 | $7 | $5 | $3 |
| Operating Expenses | $11 | $18 | $15 | $12 |
| Operating Income | $2 | -$0 | $2 | $4 |
| % Margin | 4.1% | -0.7% | 5.3% | 9.2% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $2 | -$0 | $2 | $4 |
| Tax Expense | $1 | $0 | $1 | $1 |
| Net Income | $1 | -$1 | $2 | $3 |
| % Margin | 3.7% | -1.4% | 3.4% | 6.1% |
| EPS | 0.043 | -0.022 | 0.05 | 0.09 |
| % Growth | 299.5% | -143.1% | -44.1% | – |
| EPS Diluted | 0.041 | -0.022 | 0.05 | 0.08 |
| Weighted Avg Shares Out | 32 | 32 | 32 | 30 |
| Weighted Avg Shares Out Dil | 34 | 32 | 34 | 34 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | $2 | $0 | $3 | $5 |
| % Margin | 6.3% | 0.5% | 6.7% | 11.3% |